MULTIPLE SCLEROSIS: MODERN VIEW ON THE PROBLEM (literature review)
https://doi.org/10.51523/2708-6011.2010-7-3-15
Abstract
This article is the references review of modern representations about problems of etiologic, pathogenesis, clinical displays and treatment of multiple sclerosis.
Keywords
рассеянный склероз,
этиология,
патогенез,
лечение,
multiple sclerosis,
etiologic,
pathogenesis,
treatment
About the Authors
F. V. Bahinski
Гомельская областная клиническая больница
Belarus
Belarus
N. V. Galinovskaja
Gomel State Medical University
Belarus
Belarus
N. N. Usova
Gomel State Medical University
Belarus
Belarus
V. O. Demidova
Гомельская областная клиническая больница
Belarus
Belarus
V. Ja. Latysheva
Gomel State Medical University
Belarus
Belarus
References
1. Гусев, Е. И. Рассеянный склероз и другие демиелинизирующие заболевания / Е. И. Гусев, И. А. Завалишин, А. Н. Бойко. - М.: Миклош, 2004. - 540 с.
2. John, H. Noseworthy. Multiple sclerosis / H. John // N. Engl. J. Med. - 2000. - Vol. 343. - P. 938-952.
3. Compston, A. Multiple sclerosis / A. Compston, A. Coles // Lancet. - 2002. - Vol. 359. - P. 1221-1231.
4. Sawcer, S. The complex genetic of multiple sclerosis: pitfalls and prospects / S. Sawcer // Brain - 2008. - Vol. 131. - P. 3118-3131.
5. Multiple sclerosis - a response-to-damage model / B. A. Hart [et al.] // Trends Mol. Med. - 2009. - Vol. 15. - P. 235-244.
6. Рассеянный склероз: патогенез, диагностика, дифференциальный диагноз и лечение / Т. Л. Демина [и др.] // Consilium medicum. -- 2008. -- № 1. -- С. 61-68.
7. Schneider, R. Neuronal degeneration in a viral model of multiple sclerosis / R. Schneider // J. Neurosci. - 2009. - Vol. 29. - P. 153-154.
8. Хулуп, Г. Я. Клиническая и лабораторная диагностика рассеянного склероза / Г. Я. Хулуп, Н. Ф. Филиппович. - Минск: БелМАПО. - 2005. - 180 с.
9. Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations / C. Ahlgren [et al.] // Acta Neurol Scand. - 2009. - Vol. 119. - P. 313-320.
10. Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis / J. D. Lijnemann [et al.] // Ann Neurol. - 2010. - Vol. 67 (2). - P.159-169.
11. Intrathecal immune responses to EBV in early MS / E. Jaquiéry [et al.] // Eur J Immunol. - 2010. - Vol. 40. - Р. 878-887.
12. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. / P. I W de Bakker [et al.] // Nat Genet. - 2006. - Vol. 38, № 10. - P. 1166-1172.
13. Koutsouraki, E. Epidemiology of multiple sclerosis in Europe: a review / E. Koutsouraki, V. Costa, S. Baloyannis // Int Rev Psychiatry. - 2010. - Vol. 22. - P. 2-13.
14. Dietary patterns in clinical subtypes of multiple sclerosis: an exploratory study / G. Ramsaransing [et al.] // Nutrition J. - 2009. - Vol. 8. - P. 36-41.
15. Defining and analyzing geoepidemiology and human autoimmunity / Y. Shapira [et al.] // J Autoimmun. - 2010. - Vol. 34. - P. 168-177.
16. Шмидт, Т. Е. Воспаление и нейродегенерация при рассеянном склерозе / Т. Е. Шмидт // Неврол журн. - 2006. - № 3. - С. 46-51.
17. Ehlers, S. Infection, inflammation, and chronic diseases: consequences of a modern lifestyle / S. Ehlers, S. H. Kaufmann // Trends Immunol. - 2010. - Vol. 31(5). - P.184-90.
18. Smith, A. B. Imaging evaluation of demyelinating processes of the central nervous system / A. B. Smith, J. G. Smirniotopoulos // Postgrad Med J. - 2010. - Vol. 86. - P. 218-229.
19. Chari, D. M. Remyelination in multiple sclerosis / D. M. Chari // Int Rev Neurobiol. - 2007. - Vol. 79. - P. 589-620.
20. Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis / M. Koch [et al.] // J Neurol. - 2006. - Vol. 253 (4). - P. 483-487.
21. Рассеянный склероз: диагностика и лечение / С. А. Лихачев [и др.] // Неврология и нейрохирургия в Беларуси. - 2009. - № 1. - С. 18-31.
22. Fadil, H. Differential diagnosis of multiple sclerosis. / H. Fadil, R. E. Kelley, E. Gonzalez-Toledo // Int Rev Neurobiol. - 2007. - Vol. 79. - P. 393-422.
23. Huang, D. Advances in the immune pathogenesis and treatment of multiple sclerosis / D. Huang, A. Rae-Grant // Cent Nerv Syst Agents Med Chem. - 2009. - Vol. 9 (1). - P. 20-31.
24. Treatment of multiple sclerosis in children and adolescents. / N. L. Kuntz [et al.] // Expert Opin Pharmacother. - 2010. - Vol. 11 (4). - P. 505-520.
25. Betaferon in the treatment of multiple sclerosis / M. Vidović [et al.] // Acta Clin Croat. - 2009. - Vol. 48 (4). - P. 419-421.
26. Vosoughi, R. Therapy of MS / R. Vosoughi, M. S. Freedman // Clin Neurol Neurosurg. - 2010. - Vol. 112 (5). - P. 365-385.
27. Lim, S. Y. Current and future disease-modifying therapies in multiple sclerosis / S. Y. Lim, C. S. Constantinescu // Int J Clin Pract. - 2010. - Vol. 64. - P. 637-650.
28. Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs. / G. Howard [et al.] // Curr Med Res Opin. - 2009. -- Vol. 25. - Р. 869-877.
29. Bielekova, B. Monoclonal antibodies in MS: mechanisms of action / B. Bielekova, B. L. Becker // Neurology. - 2010. - Vol. 74, № 1. - Р. 31-40.
30. Emerging oral drugs for multiple sclerosis / C. Gasperini [et al.] // Expert Opin Emerg Drugs. - 2008. - Vol. 13 (3). - P. 465-477.
Review
For citations:
Bahinski F.V., Galinovskaja N.V., Usova N.N., Demidova V.O., Latysheva V.J. MULTIPLE SCLEROSIS: MODERN VIEW ON THE PROBLEM (literature review). Health and Ecology Issues. 2010;(3):75-80. (In Russ.) https://doi.org/10.51523/2708-6011.2010-7-3-15
Views: 256
Email this article 